Used primarily in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Its structural features make it suitable for developing ligands that interact with serotonin and dopamine receptors, particularly in the study of antipsychotic and antidepressant agents. The compound's ability to cross the blood-brain barrier enhances its utility in neuropharmacology. It is also employed in structure-activity relationship (SAR) studies to optimize receptor selectivity and binding affinity in new drug candidates.